Key Takeaways Abbott posted Q2 gross profit of $6.29B, up 8.9% year over year, with margin expansion to 56.4%. Strong growth in ABT's Medical Devices and Nutrition drove a favorable product mix and higher-margin sales.FX tailwinds, and reduced COVID testing drag reinforced ABT's margin gains despite macro issues. In the second quarter, Abbott Laboratories (ABT) posted gross profit of $6.29 billion, up 8.9% year over year despite a 5.4% increase in the cost of products sold (excluding amortization expense). ...